{"id":695,"date":"2021-09-14T12:38:22","date_gmt":"2021-09-14T12:38:22","guid":{"rendered":"http:\/\/events.marketsandmarkets.com\/blog\/?p=695"},"modified":"2021-09-20T16:21:35","modified_gmt":"2021-09-20T16:21:35","slug":"catch-up-with-matt-davis-talk-on-neoantigen-targeted-cancer-immunotherapy-in-the-clinic-at-advance-genetic-sequencing-virtual-conference-2021","status":"publish","type":"post","link":"https:\/\/events.marketsandmarkets.com\/blognew\/catch-up-with-matt-davis-talk-on-neoantigen-targeted-cancer-immunotherapy-in-the-clinic-at-advance-genetic-sequencing-virtual-conference-2021\/","title":{"rendered":"Catch up with Matt Davis\u2019 talk on \u201cNeoantigen Targeted Cancer Immunotherapy in the Clinic\u201d at Advance Genetic Sequencing Virtual Conference 2021"},"content":{"rendered":"\n

Matt Davis PhD joined Gritstone Oncology (NASDAQ: GRTS) in 2015 and is currently the Director of Molecular Biology and Sequencing responsible for various neo-antigen discovery and translational genomics efforts.  Prior to Gritstone, Dr. Davis conducted post-doctoral research at Warp Drive Bio in the discovery biology group.  He holds a PhD in Genetics from Yale with thesis research under the supervision of Dr. Joseph Schlessinger and previous to his graduate work he conducted cancer genomics research at Dana Farber Cancer Institute and the Broad Institute.<\/p>\n\n\n\n

Marketsandmarkets took this opportunity to talk probe Dr. Davis’ thoughts on the newfound developments in the fields of genetic sequencing and the ways this research has been of paramount importance in overcoming the challenges of the pandemic. He also discusses her own learnings in the field, their presentation at the Conference their take on the conference program <\/p>\n\n\n\n

Question: <\/strong>What are the recent\nadvances in the genetic sequencing field and current challenges that need\nimmediate attention?<\/strong><\/p>\n\n\n\n

Dr. Davis :<\/strong><\/p>\n\n\n\n

Recent advances in single cell sequencing, cell\nfree \/ circulating tumor DNA sequencing and the cloud computing infrastructure\nthat allows teams to scale standard and more advanced (like machine learning approaches)\nanalyses for novel genomic discovery.      \n<\/p>\n\n\n\n

Current challenges in various sequencing efforts\ninclude sub optimal molecular conversion efficiencies associated with library\nconstruction \/ enrichment protocols.  As\nsequencing efforts have grown immensely over the years the data available is\ndaunting – cross training students \/ employees how to communicate across\ndisciplines is imperative<\/p>\n\n\n\n

Question: <\/strong>What\nis the key take away point from your presentation topic which will help in\nbuilding the knowledge base of attendees? \n<\/strong><\/p>\n\n\n\n

Dr. Davis :<\/strong><\/p>\n\n\n\n